Articles Posted in Mass Torts

Abbott spinal cord stimulator lawsuits are being filed by patients who say devices intended to relieve their chronic pain instead caused electrical shocks, burning sensations, worsening pain, neurological injuries, and additional surgery. Some patients say their stimulators failed after repeated reprogramming attempts. Others allege that the leads moved, that the system stopped delivering treatment, or that Abbott representatives became more involved in their medical care than they should have, putting Abbott’s interests ahead of the patients’ well-being.

That paragraph is a nutshell of what this litigation is about. The number of filed cases is low right now, but our lawyers believe this litigation will eventually involve thousands of claims. We are getting a lot of calls in these cases, and lawyers we work with are also reporting that they are developing huge inventories of these cases.

On October 2, 2026, the federal judicial panel created MDL No. 3194 to coordinate related Abbott cases for pretrial proceedings in the Northern District of Illinois. The cases are assigned to U.S. District Judge Lindsay C. Jenkins.

Our lawyers are handling Similac and Enfamil infant formula lawsuits for families whose premature babies suffered or died from necrotizing enterocolitis (NEC) after taking one of these formulas. Our law firm is reviewing NEC lawsuits in all 50 states.

Medical research links cow milk-based infant formulas such as Similac and Enfamil to a dangerous neonatal medical condition known as necrotizing enterocolitis. These newborn NEC formula lawsuits make many allegations. At their core, they allege that the makers of these formulas knew of the risk of NEC and did nothing to warn families or give them a choice.

If your premature baby was diagnosed with NEC after being given Similac or Enfamil formula, you may be able to file an NEC baby formula lawsuit against the formula companies and receive financial compensation for the harm that was done to your child.

Dupixent lawsuits are now moving forward in federal court for patients who allege the drug caused, accelerated, or unmasked cutaneous T-cell lymphoma and related T-cell lymphomas. Our lawyers are taking new cases.

On June 4, 2026, the Judicial Panel on Multidistrict Litigation centralized the federal Dupixent cases in MDL No. 3180, In re: Dupixent (Dupilumab) Products Liability Litigation, in the District of New Jersey before Judge Zahid N. Quraishi.

Dupixent, also known as dupilumab, is a biologic medication used to treat atopic dermatitis, asthma, COPD, and a host of other inflammatory conditions. For many patients, Dupixent has provided real relief where other treatments failed. But for some patients, the story has been very different and not one they could have expected.

This page provides updates on Camp Lejeune lawsuits.

Our lawyers are still working to give the latest update on the litigation, even though we are no longer taking new cases. Why? Because there is little information out there, and we are staying with victims, including those we do not represent, until the end.

We recently reopened the comments below to give you a chance to share your thoughts (and frustrations).

Our lawyers handle Paraquat lawsuits in all 50 states. This page provides the latest news and updates on Paraquat lawsuits in both state and federal courts. We also give our perspective on where this litigation is heading and provide projected settlement payouts for a viable Paraquat lawsuit.

Continue reading

Thousands of hernia mesh lawsuits are pending in courts across the country. Our hernia mesh lawyers are handling these cases in all 50 states.

The plaintiffs in these lawsuits are individuals with defective hernia mesh implanted during surgery, causing them to suffer severe post-surgical complications and injuries.

The hernia mesh lawsuits involve multiple hernia mesh products made by four medical device companies that are in (or were in) the litigation: Ethicon (a Johnson & Johnson subsidiary that has reached a settlement in most of its lawsuits), C.R. Bard (now part of Becton Dickinson), Covidien, and Atrium Medical Corp.

Breast mesh lawsuits allege that some manufacturers promoted or allowed their mesh products to become widely used in breast reconstruction, augmentation, and revision procedures despite the fact that FDA has not cleared or approved any surgical mesh product for use in breast surgery. The FDA has specifically stated that the safety and effectiveness of surgical mesh in breast surgery, including augmentation and reconstruction, has not been determined.

These internal bra lawsuits allege that manufacturers of products such as AlloDerm, GalaFLEX, Phasix, AlloMax, FlexHD, Strattice, and DuroSorb marketed their devices for breast reconstruction, augmentation, and revision surgeries even though those breast-specific applications had not been adequately studied or cleared by the FDA. Patients were not warned. Surgeons were not given enough information. So when complications developed, including infection, mesh failure, chronic pain, implant loss, breast deformity, and the need for additional surgery, many women had no reason to connect their injuries to the mesh product placed inside them.

A spinal cord stimulator is an implantable medical device used to manage chronic pain, most often involving the back or spine. These systems are marketed as a way to reduce pain by interrupting nerve signals before they reach the brain. But for a growing number of patients, the device fails to help. It introduces new and sometimes permanent problems, including electrical shocks, burning pain, infections, lead migration, hardware failure, and repeat surgeries to reposition or remove equipment that was supposed to improve quality of life.

This page explains spinal cord stimulator lawsuits and why they are being filed nationwide. It focuses on what patients are alleging, how these devices have failed in real-world use, and why many of these cases go beyond ordinary medical malpractice claims. The most serious lawsuits do not center on a single surgical mistake. They examine how modern spinal cord stimulators were designed, tested, and approved, and whether patients were ever adequately warned about the risks that now recur repeatedly in medical records and FDA reports.

Many victims want to know what spinal cord stimulator settlement amounts will look like and how we think compensation will be calculated, assuming an ultimate settlement. Settlement amounts and payouts in these cases will depend on several factors, which we dig into more fully below.

Bard PowerPort lawsuits allege that defects in implanted port catheters can cause fractures, migration, blood clots, infections, embolisms, and other serious complications. Thousands of product liability lawsuits are now pending against Bard and its parent company, Becton Dickinson, in a federal multidistrict litigation in Arizona. After a long slog, these cases are now moving forward.

The first bellwether trial ended with a partial defense verdict and a deadlocked jury on the central design defect claim. The second trial, Divelbliss v. C.R. Bard, led to a $40 million verdict. It involved an alleged fracture of a silicone Groshong catheter. The third trial, Lattanzio, ended in a defense verdict on October 30, 2026, in a catheter infection case. Five bellwether trials are scheduled through February 2027. The early results have been very different, and our lawyers remain bullish on well-documented fracture, migration, and embolization cases.

This page provides the latest Bard PowerPort lawsuit updates, projected settlement amounts, and information about who may qualify to file a claim.

Our lawyers are reviewing hair relaxer cancer lawsuits for women across the United States. These claims involve women who used chemical hair relaxers or hair straighteners for years and were later diagnosed with uterine cancer, including endometrial cancer, ovarian cancer, or serious uterine fibroids that led to a hysterectomy.

The federal hair relaxer litigation included 12,743 pending lawsuits as of November 2, 2026. The cases are moving through expert discovery and bellwether preparation in the Northern District of Illinois. This litigation has been going on for years, but there is still no global hair relaxer settlement or MDL payout program.  That does not mean our lawyers are not bullish on these cases. We are. It is just moving slowly, which is how it goes sometimes in the MDL mass torts. We still expect a favorable global settlement when all is said and done.

The strongest cases generally involve frequent, long-term use followed by uterine or ovarian cancer, a clear product history, and substantial treatment or reproductive injury.

Contact Information